JTL
DNA icon

Jupiter Topco LLC’s Ginkgo Bioworks DNA Stock Holding History

Jupiter Topco LLC’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
+14,534
New +$122K ﹤0.01% 2440

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco LLC's DNA Position: Q2 2026 in Review

Jupiter Topco LLC opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 14,534 shares worth $144K. The stake represents ﹤0.01% of the portfolio and ranks #2440 among its holdings.

167 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Jupiter Topco LLC held 14,534 shares of Ginkgo Bioworks worth $144K as of Q2 2026.
  • Ginkgo Bioworks was a new Jupiter Topco LLC position in Q2 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Jupiter Topco LLC's portfolio in Q2 2026, its #2440 holding.
  • 167 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Jupiter Topco LLC's 13F filing for Q2 2026, filed 14 Aug 2026.